Catalog No.	Product Name	Information	Selective / Pan	IC50 / Ki
S9779	Emavusertib (CA-4948)	Emavusertib (CA-4948) is a potent and orally bioavailable inhibitor of interleukin-1 receptor-associated kinase 4/FMS-like Tyrosine Kinase 3 (IRAK4/FLT3) with anti-tumor activity.	Selective
S8562	IRAK4-IN-2	IRAK4-IN-2 is a reversible kinase inhibitor that modulates IRAK4 function in both the toll-like receptor (TLR) and interleukin 1 receptor (IL-1R) signaling cascades.	Selective
S8531	Zimlovisertib (PF-06650833)	Zimlovisertib (PF-06650833) is a potent, selective inhibitor of IRAK4 with an IC50 of 0.2 nM.	Selective	IRAK4, IC50: 0.2 nM
S0775	IRAK4-IN-4	IRAK4-IN-4 (compound 15) is an inhibitor of interleukin-1 receptor–associated kinase 4 (IRAK4) and cyclic GMP-AMP synthase (cGAS) with IC50 of 2.8 nM and 2.1 nM, respectively.	Selective	IRAK4, IC50: 2.8 nM
S0008	IRAK4-IN-1	IRAK4-IN-1 is an interleukin-1 receptor associated kinase 4 (IRAK4) inhibitor with IC50 of 7 nM.	Selective	IRAK4, IC50: 7 nM
S2039	IRAK inhibitor 6	IRAK inhibitor 6 is a selective Interleukin-1 receptor-associated kinase 4(IRAK4) inhibitor with IC50 of 0.16 μM.	Selective	IRAK4, IC50: 0.16 μM
S9701	HS-243	HS-243 is a highly potent interleukin-1 receptor-associated kinase (IRAK) inhibitor with IC50 of 24 nM, 20 nM and 0.5 μM for IRAK-1, IRAK-4 and TAK1, respectively.	Pan	IRAK-4, IC50: 20 nM
S8663	Takinib	Takinib is a potent and selective TAK1 inhibitor with an IC50 of 9.5 nM, more than 1.5 log more potent than the second and third ranked targets, IRAK4 (120 nM) and IRAK1 (390 nM), respectively. Takinib induces apoptosis.	Pan	IRAK4, IC50: 120 nM
S6598	IRAK-1-4 Inhibitor I	IRAK-1-4 Inhibitor I is an inhibitor of interleukin-1 receptor associated kinase (IRAK) with IC50 values of 0.3 μM and 0.2 μM for IRAK-1 and IRAK-4, respectively. It displays IC50 values >10 µM in a panel of 27 other kinases tested.	Pan	IRAK-4, IC50: 0.2 μM

IRAK4 Selective Inhibitors